| Literature DB >> 1691067 |
Abstract
Bleomycin is recognized to cause an interstitial pneumonitis that can lead to fibrosis. Although its occurrence may be sporadic, some factors may increase the risk of such a pulmonary reaction. In this article the clinical setting and presentation, radiographic manifestations, pathologic findings, and the prognosis of bleomycin-induced interstitial fibrosis are described. Additionally, the role of pulmonary function tests in monitoring patients for toxicity is discussed.Entities:
Mesh:
Substances:
Year: 1990 PMID: 1691067
Source DB: PubMed Journal: Clin Chest Med ISSN: 0272-5231 Impact factor: 2.878